>
Syncona logo

SYNC - Syncona Share Price

245.5p -4.0  -1.6%

Last Trade - 09/04/21

Sector
Financials
Size
Mid Cap
Market Cap £1.63bn
Enterprise Value £1.63bn
Revenue £63.2m
Position in Universe 351st / 1817
Bullish
Bearish
Unlock SYNC Revenue
Momentum
Relative Strength (%)
1m -8.26%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -12.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
55.3 5.02 85.9 196.4 439.1 -167.3 36.0 36.0
+239.4 +59.2 +130.5
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 September 2020, SynconaLtd revenues increased from -£94.8M to £135.7M. Net incometotaled £119.9M vs. loss of £105.2M. Revenues reflect NetLoss - Fin Instruments Fair Value increase from -£120.9M to£122.8M. Basic Earnings per Share excluding ExtraordinaryItems increased from -£0.16 to £0.18.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for SYNC
Graphical History

Revenue

SYNC Revenue Unlock SYNC Revenue

Net Income

SYNC Net Income Unlock SYNC Revenue

Normalised EPS

SYNC Normalised EPS Unlock SYNC Revenue

PE Ratio Range

SYNC PE Ratio Range Unlock SYNC Revenue

Dividend Yield Range

SYNC Dividend Yield Range Unlock SYNC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
SYNC EPS Forecasts Unlock SYNC Revenue
Profile Summary

Syncona Ltd is a closed-ended investment healthcare company which focuses on investing in and building global leaders in life science. The Company operates in two segments: life science portfolio and fund investments. The Company’s portfolio is made up of a small group of healthcare companies. The Company intends to achieve the investment objective through investments in long-only funds, hedge funds, private equity funds, infrastructure funds, credit and fixed income and real estate funds. The Company makes its life science investments through Syncona Holdings Limited. The Company makes its fund investments through Syncona Investments LP Incorporated.

Directors
Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated August 14, 2012
Public Since October 26, 2012
No. of Shareholders: n/a
No. of Employees: n/a
SYNC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SYNC
Upcoming Events for SYNC
Monday 7th June, 2021 Estimate
Full Year 2021 Syncona Ltd Earnings Release
Wednesday 28th July, 2021 Estimate
Syncona Ltd Annual Shareholders Meeting
Frequently Asked Questions for Syncona
What is the Syncona share price?

As of 09/04/21, shares in Syncona are trading at 245.5p, giving the company a market capitalisation of £1.63bn. This share price information is delayed by 15 minutes.

How has the Syncona share price performed this year?

Shares in Syncona are currently trading at 245.5p and the price has moved by 6.05% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Syncona price has moved by -14.32% over the past year.

What are the analyst and broker recommendations for Syncona?

Of the analysts with advisory recommendations for Syncona, there are there are currently 0 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Syncona is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Syncona next release its financial results?

Syncona is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Syncona dividend yield?

Syncona does not currently pay a dividend.

Does Syncona pay a dividend?

Syncona does not currently pay a dividend.

When does Syncona next pay dividends?

Syncona does not currently pay a dividend.

How do I buy Syncona shares?

To buy shares in Syncona you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Syncona?

Shares in Syncona are currently trading at 245.5p, giving the company a market capitalisation of £1.63bn.

Where are Syncona shares listed? Where are Syncona shares listed?

Here are the trading details for Syncona:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: SYNC
What kind of share is Syncona?

Based on an overall assessment of its quality, value and momentum, Syncona is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Syncona share price forecast 2021?

Shares in Syncona are currently priced at 245.5p. At that level they are trading at 9.98% discount to the analyst consensus target price of 272.72.

How can I tell whether the Syncona share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Syncona. Over the past six months, the relative strength of its shares against the market has been -19.86%. At the current price of 245.5p, shares in Syncona are trading at -3.08% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Syncona PE Ratio?

The Syncona PE ratio based on its reported earnings over the past 12 months is 58.61. The shares are currently trading at 245.5p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Syncona?

Syncona's management team is headed by:

Thomas Henderson - NED
Nigel Keen - NED
Martin Murphy - CEX
Christopher Hollowood - OTH
John Bradshaw - OTH
Edward Hodgkin - OTH
Alex Hamilton - OTH
Magdalena Jonikas - OTH
Freddie Dear - OTH
Melanie Gee - NEC
Michael Kyriakides - OTH
Kemal Malik - NED
Danny Bar-Zohar - OTH
Gonzalo Garcia - OTH
Virginia Holmes - NED
Who are the major shareholders of Syncona?

Here are the top five shareholders of Syncona based on the size of their shareholding:

Wellcome Trust Endowment Fund
Percentage owned: 27.99% (186.0m shares)
Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund
Percentage owned: 5.04% (33.5m shares)
Waverton Investment Management Ltd. Investment Advisor/Hedge Fund
Percentage owned: 3.04% (20.2m shares)
T. Rowe Price International (UK) Ltd. Investment Advisor/Hedge Fund
Percentage owned: 1.46% (9.69m shares)
T. Rowe Price International Discovery Fund Mutual Fund
Percentage owned: 1.39% (9.24m shares)
Similar to SYNC
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.